Superoxide dismutase analogue (LTT Bio-Pharma)

N/A

Report date: 2025/07/17 17:48:21

Base Information

Drug NameSuperoxide dismutase analogue (LTT Bio-Pharma)
Drug Alias NameLecithin-modified superoxide dismutase卵磷脂修饰超氧化物歧化酶Recombinant midismaseLT-1001LT-0011 +[8] 
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionSuperoxide dismutase replacementantioxidant
TargetsSuperoxide dismutase
Therapy Area/IndicationsMyocardial InfarctionPeripheral Nervous System DiseasesStroke +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLTT Bio-Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLTT Bio-Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionPeripheral Nervous System DiseasesStroke +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A